{"title":"Primary Cutaneous Large B Cell Lymphoma, Leg Type: Good Evolution of A Particular Location","authors":"Lahlou A, E. S, B. H, Mernissi Fz","doi":"10.19070/2332-2977-1600024","DOIUrl":null,"url":null,"abstract":"Primary cutaneous B-cell lymphomas are a heterogeneous group of rare clonal B-cell lymphoproliferative disorders with distinct clinicopathological features compared with nodal counterparts [1]. Primary cutaneous diffuse large B-cell lymphoma-leg type (PCLBCL-LT) is a rare subtype which constitutes only 4% [2]. They have a predilection to the leg (72%), advanced age of onset (mean age, 76 years), high Bcl-2 expression (85%) and frequent relapses with extracutaneous dissemination [10-20%]. We report a case we report the case of a young patient of 39 years old who consulted for a hummocky tumor in the back whose histology was in favor of lymphoma B-type leg, with good response to rituximab combined with doxorubicin, cyclophosphamide, vincristine, and prednison (R-CHOP).","PeriodicalId":15418,"journal":{"name":"Journal of Clinical Dermatology","volume":"42 1","pages":"90-93"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19070/2332-2977-1600024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Primary cutaneous B-cell lymphomas are a heterogeneous group of rare clonal B-cell lymphoproliferative disorders with distinct clinicopathological features compared with nodal counterparts [1]. Primary cutaneous diffuse large B-cell lymphoma-leg type (PCLBCL-LT) is a rare subtype which constitutes only 4% [2]. They have a predilection to the leg (72%), advanced age of onset (mean age, 76 years), high Bcl-2 expression (85%) and frequent relapses with extracutaneous dissemination [10-20%]. We report a case we report the case of a young patient of 39 years old who consulted for a hummocky tumor in the back whose histology was in favor of lymphoma B-type leg, with good response to rituximab combined with doxorubicin, cyclophosphamide, vincristine, and prednison (R-CHOP).